Sigyn Therapeutics, Inc. (SIGY) stock
SIGYOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.03+0.00 (0.00%)
Close on Oct 19, 2026Market cap $48.16KP/E –Yield –
Sigyn Therapeutics cash
Cash and short-term investments held at the end of each period.
Sigyn Therapeutics's cash was $85.57K at Sep 30, 2025. For fiscal 2024 it was $12.14K, up 3.9% from the year before. Over ten years it grew 62.4% a year on average. The highest annual figure on record is $638.82K in fiscal 2015.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $12.14K | +3.9% |
| FY2023 | Dec 31, 2023 | $11.69K | +39.9% |
| FY2022 | Dec 31, 2022 | $8.36K | -97.5% |
| FY2021 | Dec 31, 2021 | $340.96K | +304.0% |
| FY2020 | Dec 31, 2020 | $84.40K | +16780.4% |
| FY2019 | Dec 31, 2019 | $500 | -93.3% |
| FY2018 | Dec 31, 2018 | $7.50K | -21.8% |
| FY2017 | Dec 31, 2017 | $9.59K | -93.6% |
| FY2016 | Dec 31, 2016 | $149.61K | -76.6% |
| FY2015 | Dec 31, 2015 | $638.82K | +672346.3% |
| FY2014 | Dec 31, 2014 | $95 | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2025 | Sep 30, 2025 | $85.57K | -48.1% |
| Q2 FY2025 | Jun 30, 2025 | $459 | -99.1% |
| Q1 FY2025 | Mar 31, 2025 | $12.90K | -60.7% |
| Q4 FY2024 | Dec 31, 2024 | $12.14K | +3.9% |
| Q3 FY2024 | Sep 30, 2024 | $164.79K | +155.2% |
| Q2 FY2024 | Jun 30, 2024 | $53.64K | +127.0% |
| Q1 FY2024 | Mar 31, 2024 | $32.84K | -89.8% |
| Q4 FY2023 | Dec 31, 2023 | $11.69K | +39.9% |
| Q3 FY2023 | Sep 30, 2023 | $64.58K | +129.6% |
| Q2 FY2023 | Jun 30, 2023 | $23.63K | +224.1% |
| Q1 FY2023 | Mar 31, 2023 | $322.33K | +296.1% |
| Q4 FY2022 | Dec 31, 2022 | $8.36K | -97.5% |
| Q3 FY2022 | Sep 30, 2022 | $28.12K | -94.4% |
| Q2 FY2022 | Jun 30, 2022 | $7.29K | -99.3% |
| Q1 FY2022 | Mar 31, 2022 | $81.39K | +1045.1% |
| Q4 FY2021 | Dec 31, 2021 | $340.96K | +304.0% |
| Q3 FY2021 | Sep 30, 2021 | $502.98K | +55172.1% |
| Q2 FY2021 | Jun 30, 2021 | $1.06M | +85452.6% |
| Q1 FY2021 | Mar 31, 2021 | $7.11K | +1321.4% |
| Q4 FY2020 | Dec 31, 2020 | $84.40K | +16780.4% |
| Q2 FY2020 | Jun 30, 2020 | $910 | -90.2% |
| Q1 FY2020 | Mar 31, 2020 | $1.24K | -6.9% |
| Q4 FY2019 | Dec 31, 2019 | $500 | -93.3% |
| Q3 FY2019 | Sep 30, 2019 | $500 | -93.8% |
| Q2 FY2019 | Jun 30, 2019 | $9.27K | -1.2% |
| Q1 FY2019 | Mar 31, 2019 | $1.33K | -96.8% |
| Q4 FY2018 | Dec 31, 2018 | $7.50K | -21.8% |
| Q3 FY2018 | Sep 30, 2018 | $8.13K | -62.8% |
| Q2 FY2018 | Jun 30, 2018 | $9.38K | -70.8% |
| Q1 FY2018 | Mar 31, 2018 | $41.30K | +348.0% |
| Q4 FY2017 | Dec 31, 2017 | $9.59K | -93.6% |
| Q3 FY2017 | Sep 30, 2017 | $21.86K | -42.4% |
| Q2 FY2017 | Jun 30, 2017 | $32.16K | -77.7% |
| Q1 FY2017 | Mar 31, 2017 | $9.22K | -97.1% |
| Q4 FY2016 | Dec 31, 2016 | $149.61K | -76.6% |
| Q3 FY2016 | Sep 30, 2016 | $37.96K | – |
| Q2 FY2016 | Jun 30, 2016 | $144.39K | – |
| Q1 FY2016 | Mar 31, 2016 | $317.97K | – |
| Q4 FY2015 | Dec 31, 2015 | $638.82K | – |
See a number that looks wrong?